<Header>
<FileStats>
    <FileName>20161116_10-Q-A_edgar_data_1011060_0001011060-16-000047_1.txt</FileName>
    <GrossFileSize>911262</GrossFileSize>
    <NetFileSize>5929</NetFileSize>
    <ASCII_Embedded_Chars>88295</ASCII_Embedded_Chars>
    <HTML_Chars>105266</HTML_Chars>
    <XBRL_Chars>346510</XBRL_Chars>
    <XML_Chars>358323</XML_Chars>
    <N_Tables>2</N_Tables>
    <N_Exhibits>6</N_Exhibits>
</FileStats>
<SEC-Header>
0001011060-16-000047.hdr.sgml : 20161116
<ACCEPTANCE-DATETIME>20161116131052
ACCESSION NUMBER:		0001011060-16-000047
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		40
CONFORMED PERIOD OF REPORT:	20160930
FILED AS OF DATE:		20161116
DATE AS OF CHANGE:		20161116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AdvanSource Biomaterials Corp
		CENTRAL INDEX KEY:			0001011060
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043186647
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11737
		FILM NUMBER:		162001953

	BUSINESS ADDRESS:	
		STREET 1:		229 ANDOVER STREET
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		978-657-0075

	MAIL ADDRESS:	
		STREET 1:		229 ANDOVER STREET
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CARDIOTECH INTERNATIONAL INC
		DATE OF NAME CHANGE:	19960321

</SEC-Header>
</Header>

 0001011060-16-000047.txt : 20161116

10-Q/A
 1
 asnb160930qa_10qz.htm
 160930 ASNB FORM 10-Q/A #1

U 

UNITED STATES  
  
    SECURITIES AND EXCHANGE COMMISSION  
  
    Washington, D.C. 20549  
  
    Form 10-Q/A  
  
    (Amendment No. 1)  

AdvanSource Biomaterials Corporation  
  
    (Exact name of registrant as specified in its charter)  
  
    Delaware  
 (State or other jurisdiction of 
 incorporation or organization) 
         04-3186647  
 (I.R.S. Employer Identification No.) 
  
    229 Andover Street, Wilmington, Massachusetts  
 (Address of principal executive offices) 
         01887  
 (Zip Code) 

(978) 657-0075 
  
   (Registrant s telephone number, including area code) 

(Former name, former address and former fiscal year, if changed since last report) 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes        No       
  
   Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes         No        
  
   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of    large accelerated filer,       accelerated filer    and smaller reporting company    in Rule 12b-2 of the Exchange Act.  (Check one): 
  
         Large Accelerated Filer                                                                              Accelerated Filer  
  
         Non-accelerated Filer                                                                                 Smaller reporting company  
  
   Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes           No       
  
   As of November 11, 2016, there were 21,490,621 shares of the registrant   s Common Stock outstanding. 

EXPLANATORY PARAGRAPH  
   This Amendment No. 1 on Form 10-Q/A (   Amendment No. 1   ) amends our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2016, originally filed on November 14, 2016 (the  Original Filing ). We are filing this Amendment No. 1 to include the updated Interactive Data Files (Exhibit 101) formatted in XBRL ( Extensible Business Reporting Language ) as required by Rule 405 of Regulation S-T. We are also filing currently dated certifications of our Chief Executive Officer and Chief Financial Officer (Exhibits 31.1, 31.2, and 32.1), as required under Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.   
 No changes have been made to the Original Filing other than the furnishing of the exhibits as set forth in Item 6 herein. This Amendment No. 1 continues to speak as of the Original Filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the Original Filing date, and does not modify or update in any way disclosures made in the Form 10-Q. 

PART II.  
  OTHER INFORMATION  
       
   Item 6.  
  Exhibits  
      
    Exhibit No.  
    Description  
  
   31.1* 
   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 
  
   31.2* 
   Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 
  
   32.1* 
   Certification of Principal Executive, Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 
  
   101.INS** 
   XBRL Instance Document. 
  
   101.SCH** 
   XBRL Taxonomy Extension Schema Document. 
  
   101.CAL** 
   XBRL Taxonomy Extension Calculation Linkbase Document. 
  
   101.LAB** 
   XBRL Taxonomy Extension Label Linkbase Document. 
  
   101.PRE** 
   XBRL Taxonomy Extension Presentation Linkbase Document. 
  
   101.DEF** 
   XBRL Taxonomy Extension Definition Linkbase Document. 

* 
   Included herewith. 
  
   ** 
   Filed with this report in accordance with Rule 406T of Regulation S-T, the information in these exhibits shall not be deemed to be  filed  for purposes of Section 18 of the Exchange Act or otherwise subjected to liability under that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing. 

SIGNATURES  
 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

AdvanSource Biomaterials Corporation  
  
        By: 
   /s/ Michael F. Adams 
  
             Michael F. Adams 
  President and Chief Executive Officer  
 (Principal Executive, Financial and Accounting Officer) 

<EX-101.CAL>
 2
 asnb-20160930_cal.xml
 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

</EX-101.CAL>

<EX-101.DEF>
 3
 asnb-20160930_def.xml
 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

</EX-101.DEF>

<EX-101.INS>
 4
 asnb-20160930.xml
 XBRL INSTANCE DOCUMENT

</EX-101.INS>

<EX-101.LAB>
 5
 asnb-20160930_lab.xml
 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT

</EX-101.LAB>

<EX-101.PRE>
 6
 asnb-20160930_pre.xml
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

</EX-101.PRE>

<EX-101.SCH>
 7
 asnb-20160930.xsd
 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

</EX-101.SCH>

